Literature DB >> 5653197

Feminizing adrenocortical carcinoma with hypertension.

S S Solomon, S P Swersie, C A Paulsen, E G Biglieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5653197     DOI： 10.1210/jcem-28-5-608

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

1.  Feminizing adrenocortical tumor. Histological and ultrastructural study.

Authors:  H Mitschke; W Saeger; H J Breustedt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-04-17

2.  Feminizing adrenocortical carcinoma in a postmenopausal woman.

Authors:  B Barcelo; J Abascal; J Ardaiz; P Gil; A Colas; J Menendez; J L Inchausti
Journal:  Postgrad Med J       Date:  1979-06       Impact factor: 2.401

3.  Dexamethasone-suppressible feminizing adrenal adenoma.

Authors:  M Paja; S Díez; T Lucas; A Ojeda; L Salto; J Estrada
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

4.  Fecal and salivary electrolytes in the diagnosis of primary aldosteronism.

Authors:  D R Wilson; J C Laidlaw; J L Ruse
Journal:  Can Med Assoc J       Date:  1971-12-18       Impact factor: 8.262

5.  11-Deoxycorticosterone Producing Adrenal Hyperplasia as a Very Unusual Cause of Endocrine Hypertension: Case Report and Systematic Review of the Literature.

Authors:  Queralt Asla; Helena Sardà; Enrique Lerma; Felicia A Hanzu; María Teresa Rodrigo; Eulàlia Urgell; José Ignacio Pérez; Susan M Webb; Anna Aulinas
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.